Telmisartan in Respiratory Failure Due to COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Respiratory Distress Syndrome, Adult
- Respiratory Insufficiency
- Telmisartan
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04510662
- Collaborators
- National Polytechnic Institute, Mexico
- Investigators
- Principal Investigator: Abraham Edgar Gracia-Ramos, MD MSc Hospital Regional de Alta Especialidad de Zumpango